Effects of hyperglycemia on quantitative liver functions by the galactose load test in diabetic rats

Metabolism: Clinical and Experimental

Volumn 56, Issue 9, 2007, Pages 1265-1269

  Young, Ton Ho ^a,b   Tang, Hung Shang ^b   Lee, Herng Sheng ^c   Hsiong, Cheng Huei ^a   Hu, Oliver Yoa Pu ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b CARDINAL TIEN HOSPITAL   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; GALACTOSE; GLUCOSE; STREPTOZOCIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; LIVER FUNCTION TEST; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; GALACTOSE; HYPERGLYCEMIA; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34547662258     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2007.05.002     Document Type: Article

References (27)

1. Cuatrecasas P., and Segal S. Mammalian galactokinase. Developmental and adaptive characteristics in the rat liver. J Biol Chem 240 (1965) 2382-2388
2. Ballard F.J. Purification and properties of galactokinase from pig liver. Biochem J 98 (1966) 347-352
3. Craik J.D., and Elliott K.R. Transport of d-fructose and d-galactose into isolated rat hepatocytes. Biochem J 192 (1980) 373-375
4. Keiding S., Johansen S., and Tonnesen K. Kinetics of ethanol inhibition of galactose elimination in perfused pig liver. Scand J Clin Lab Invest 37 (1977) 487-494
5. Hu O.Y., Hu T.M., and Tang H.S. Determination of galactose in human blood by high-performance liquid chromatography: comparison with an enzymatic method and application to the pharmacokinetic study of galactose in patients with liver dysfunction. J Pharm Sci 84 (1995) 231-235
6. Keiding S. Galactose elimination capacity in the rat. Scand J Clin Lab Invest 31 (1973) 319-325
7. Lindskov J. The quantitative liver function as measured by the galactose elimination capacity. I. Diagnostic value and relations to clinical, biochemical, and histological findings in patients with steatosis and patients with cirrhosis. Acta Med Scand 212 (1982) 295-302
8. Tang H.S., and Hu O.Y. Assessment of liver function using a novel galactose single point method. Digestion 52 (1992) 222-231
9. Hu O.Y., Tang H.S., and Chang C.L. The influence of chronic lobular hepatitis on pharmacokinetics of cefoperazone-a novel galactose single-point method as a measure of residual liver function. Biopharm Drug Dispos 15 (1994) 563-576
10. Hu O.Y., Tang H.S., and Chang C.L. Novel galactose single point method as a measure of residual liver function: example of cefoperazone kinetics in patients with liver cirrhosis. J Clin Pharmacol 35 (1995) 250-258
11. Hu O.Y., Tang H.S., Sheeng T.Y., Chen T.C., and Curry S.H. Pharmacokinetics of promazine in patients with hepatic cirrhosis-correlation with a novel galactose single point method. J Pharm Sci 84 (1995) 111-114
12. Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Pharmacokinetics in patients with impaired hepatic function: study design, data analysis, and impact on dosing and labeling. Guidance for Industry (2003), Rockville, MD: US Department of Health and Human Service 5
13. Hu O.Y., Hsiong C.H., Young T.H., and Tang H.S. Assessment of rat liver function using galactose single point method. AAPS J 7 (2006) T3275
14. Mion F., Geloen A., and Minaire Y. Effects of ethanol and diabetes on galactose oxidative metabolism and elimination in rats. Can J Physiol Pharmacol 77 (1999) 182-187
15. Mion F., Rousseau M., Scoazec J.Y., Berger F., and Minaire Y. [13C]-Galactose breath test: correlation with liver fibrosis in chronic hepatitis C. Eur J Clin Invest 29 (1999) 624-629
16. Tygstrup N. The galactose elimination capacity in control subjects and in patients with cirrhosis of the liver. Acta Med Scand 175 (1964) 281-289
17. Carlisle R., Galambos J.T., and Warren W.D. The relationship between conventional liver tests, quantitative function tests, and histopathology in cirrhosis. Dig Dis Sci 24 (1979) 358-362
18. Lamesch P., Ringe B., Oellerich M., Burdelski M., Beyrau R., Gubernatis G., et al. Assessment of liver function in the early postoperative period after liver transplantation with ICG, MEGX, and GAL tests. Transplant Proc 22 (1990) 1539-1541
19. Tengstrom B. An intravenous galactose tolerance test and its use in hepatobiliary diseases. Acta Med Scand 183 (1968) 31-40
20. Keiding S., Johansen S., and Winkler K. Hepatic galactose elimination kinetics in the intact pig. Scand J Clin Lab Invest 42 (1982) 253-259
21. Williams C.A., Phillips T., and Macdonald I. The influence of glucose on serum galactose levels in man. Metabolism 32 (1983) 250-256
22. Shreeve W.W. Impaired oxidation of carbon-labeled galactose by alcoholic or diabetic liver in vivo. Nuklearmedizin 26 (1987) 159-166
23. Salaspuro M.P., and Kesaniemi Y.A. Intravenous galactose elimination tests with and without ethanol loading in various clinical conditions. Scand J Gastroenterol 8 (1973) 681-686
24. Samols E., and Dormandy T.L. Insulin response to fructose and galactose. Lancet 1 (1963) 478-479
25. Herman R.H., and Zakim D. The galactose metabolic pathway. Am J Clin Nutr 21 (1968) 127-129
26. Rogers S., and Segal S. Changing activities of galactose-metabolizing enzymes during perfusion of suckling-rat liver. Am J Physiol 240 (1981) E333-E339
27. Martin A., Rambal C., Berger V., Perier S., and Louisot P. Availability of specific sugars for glycoconjugate biosynthesis: a need for further investigations in man. Biochimie 80 (1998) 75-86